BACKGROUND: enhanced recovery after surgery programs in colorectal surgery aim to attenuate the surgical stress response, reduce complications and shorten hospital stay.
W ith traditional perioperative care, patients undergoing elective colorectal resection can have a complication rate of 20% to 30% and a postoperative hospital stay of 6 to 12 days.
1,2 the use of health care resources and costs are related to the length of hospital stay and the extent of postoperative morbidity. the key
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factors that keep a patient in the hospital after colorectal surgery are pain, paralytic ileus, postoperative complications, and other organ dysfunction. 1, 3 to improve this problem, fast-track surgery or the enhanced recovery after surgery (eRas) programs have been developed. [4] [5] [6] these programs combine techniques for the care of patients undergoing elective surgery and limit the surgical stress response and organ dysfunction, reducing postoperative complications and recovery time. 7 for colorectal surgery, a working group developed and modified consensus guidelines for eRas programs in 2005 and 2009. 8, 9 these eRas programs address 20 issues, including preadmission information and counseling, standard anesthetic protocol, prevention of postoperative ileus, laparoscopy-assisted surgery, postoperative analgesia, postoperative nutritional care, and early mobilization.
meta-analyses have shown that eRas programs are associated with a significantly reduced length of hospital stay and complications but not readmission rates and mortality. [10] [11] [12] [13] [14] [15] [16] however, evidence has not been strong because of limited data. although eRas programs may be safe, the inclusion of these programs in the standard of care has not been justified because of the low quality of clinical trials and lack of sufficient additional outcome parameters. 16 therefore, more specific and larger randomized controlled trials are needed. 16 furthermore, previous meta-analyses had not strictly followed the guidelines of the eRas group, 8, 9 and the definition of eRas programs differed between these meta-analyses.
more recently published randomized controlled trials are available that have compared eRas programs with traditional care in patients undergoing elective colorectal surgery. the purpose of the present meta-analysis was to assess the safety and efficacy of eRas programs in patients undergoing elective colorectal surgery in comparison with traditional postoperative care. the present meta-analysis was performed consistent with the recommendations of the Preferred Reporting items for systematic Reviews and meta-analyses (PRisma) statement. 17 
MATERIALS AND METHODS
Literature Search studies published between January 1966 and July 2012 were searched in Pubmed, embase, and the Cochrane Central Register of Controlled trials. no language restrictions were applied. to ensure that no clinical trials were overlooked, the reference lists of identified articles, previous meta-analyses, and review articles were manually searched to identify additional studies. article titles and abstracts were screened, and full texts were reviewed independently by 2 reviewers (C.L.Z. and X.Z.Y.); discrepancies were resolved by discussion between the reviewers. We used the following search strategy for Pubmed: (("fast track") oR (eRas) oR ("enhanced recovery surgery") oR multimodal [tiab] or laparoscopy) for malignant or benign disease were eligible for inclusion. according to the guidelines of the eRas group, there are 20 items in the eRas programs. 9 Because some items might have been implemented in modern traditional care, we made an arbitrary decision that eRas programs study should include at least 7 items. studies were required to report at least 1 of the outcome measures mentioned below. When more than 1 version of the same study was found, only the most recent version was included. When there was overlap between the results of studies reported by the same institution or authors, the larger, higher-quality study was included. excluded studies 1) were not randomized controlled trials (such as nonrandomized, quasi-randomized, pseudorandomized, or clinical controlled trials or cohort or retrospective studies); 2) had <7 items applied in the eRas group; 3) had no documentation of individual items of the eRas programs; 4) had no data available for the present meta-analysis; or 5) involved emergency surgery.
Data Extraction and Outcome Measures
all eligible studies were reviewed, and all relevant data were extracted independently by 2 reviewers (C.l.Z. and X.Z.Y.) by the use of a specifically designed data extraction form. Discrepancies were resolved by discussion between the reviewers and review of the original articles. extracted information from each eligible study included 1) study information, including name of the first author, year of publication, country, and number of patients in each group; 2) patient information including age, sex, Bmi, asa classification, and type of surgery; 3) number of eRas program items according to the guidelines of the eRas group 9 ; and 4) follow-up time and outcome measures.
Primary outcome measures included 1) primary postoperative hospital stay (defined as the number of days in hospital after surgery until discharge); 2) total postoperative hospital stay (defined as primary hospital stay plus the additional hospital days for patients who were readmitted within 30 days after surgery); 3) readmission rates; 4) total postoperative complications (defined as any complication reported within the postoperative period, excluding mortality), including general (including cardiac, respiratory, thromboembolic, urinary tract, and other nonsurgical complications) and surgical complications (including anastomotic leak, wound infection, persistent ileus, bleeding, gastric retention, incisional hernia, adhesions, abdominal sepsis, intraabdominal abscess, and other surgical complications) 18 ; and 5) mortality.
secondary outcome measures included 1) time to first passage of flatus and stool and 2) hospital costs.
Assessment of Risk of Bias
the quality of methodology of the included randomized controlled trials was assessed independently by 2 reviewers (C.L.Z. and X.Z.Y.) with the use of the Cochrane Collaboration's risk of bias tool, 19 and discrepancies were resolved by discussion between the reviewers. the 7 domains assessed were 1) random sequence generation, 2) allocation concealment, 3) blinding of participants and personnel, 4) blinding of outcome assessment, 5) incomplete outcome data, 6) selective reporting, and 7) other bias. the risk of bias for each domain was rated as high (seriously weakens confidence in the results), low (unlikely to seriously alter the results), or unclear.
Statistical Analysis meta-analyses were performed by using relative risk (RR) for dichotomous outcomes and weighted mean difference (WmD) for continuous outcomes. Pooled estimates were presented with 95% Cis. Data reported as medians and ranges or medians and interquartile ranges were converted to means and sD. 19, 20 the presence and amount of heterogeneity were assessed with Q test and i 2 index, and p < 0.1 was considered statistically significant. 21 ,22 a random-effects model was used for pooling when there was evidence of heterogeneity; otherwise, a fixed-effects model was used. funnel plots were created to determine the presence of publication bias, and asymmetry of each funnel plot was evaluated with egger weighted linear regression test, with p < 0.1 considered significant. 23 for all other comparisons, statistical significance was defined by p < 0.05, and all tests were 2-sided. Data analysis was performed with Review manager software version 5.1 from the Cochrane Collaboration and stata version 12.0 (stataCorp, College Station, TX). Some outcomes were not analyzed but were presented in a descriptive way.
Assessing Quality of Evidence the quality of evidence for each outcome measure was rated with the Grading of Recommendations assessment, Development, and evaluation (GRaDe) system, 24 as recommended by the Cochrane Collaboration. the quality of evidence for each outcome measure was rated as high (further research is very unlikely to change our confidence in the estimate of effect), moderate (further research is likely to have an important impact on our confidence in the estimate of effect and may change the estimate), low (further research is very likely to have an important impact on our confidence in the estimate of effect and is likely to change the estimate), or very low (any estimate of effect is very uncertain). the analyses were performed with GRaDepro software version 3.6 (http://ims.cochrane.org/revman/gradepro). 
RESULTS
in the initial literature search, 306 potentially relevant studies were identified; 13 studies (total, 1910 patients) were included in the meta-analysis ( fig. 1 ). [25] [26] [27] [28] [29] [30] [31] [32] [33] [34] [35] [36] [37] there were 2 studies that included patients treated in multiple centers, 32, 33 and the others were single-center studies. there were 8 studies (1522 patients) that were published after the previous meta-analyses. 28, [31] [32] [33] [34] [35] [36] [37] Preadmission information and counseling figure 2 shows evaluation of risk of bias for the included trials. eight trials used adequate methods for generating allocation sequence. sealed envelopes were used for generating allocation in 3 trials, which did not report the exact allocation sequence. 25, 26, 31 in 2 trials, the allocations were described as "randomized," but the detailed method was not specified. 35, 36 adequate methods for allocating concealment were used in 6 trials, but concealment of the allocation sequence was not sufficiently described in the other 7 trials. none of the included trials used blinding for the surgeons or patients because of the character of the eRas interventions that were compared. only 1 trial performed adequate blinding of assessors. 34 all included trials were at low risk of bias for incomplete outcome data. all recorded outcomes were reported in 9 studies, but 2 studies did not record measured outcomes. 27, 31 in 2 studies, some recorded outcomes were not reported.
30,37 none of the included trials were completely free from other bias. ten studies were at high risk for other bias because the groups were hospitalized on the same ward and/or there was low compliance with eRas items. the groups were hospitalized on different wards in 3 studies, but the risk of other bias in these studies was unclear because the compliance with eRas items was not reported. 27, 35, 37 the number of eRas items applied in the 13 studies contained a mean of 11 (range, 8-15) of the 20 eRas items according to the guidelines of the eRas group. 9 the exact items used in each study are listed in 
Secondary Outcome Measures
time to first passage of flatus was reported in 6 studies, and this was significantly reduced for the eRas group (WmD, −1.02 days; 95% Ci, −1.36 to −0.67 days; p < 0.00001), with some evidence of heterogeneity between trials (χ 2 = 299.80, p < 0.00001, i 2 = 98%) ( fig. 10 ). time to first passage of stool was reported in 6 trials, and this was significantly reduced for the eRas group (WmD, −1.12 days; 95% Ci, −1.37 to −0.87 days; p < 0.00001), with some evidence of heterogeneity between trials (χ 2 = 39.06, p < 0.00001, i 2 = 85%) ( fig. 11 ). hospital costs were reported in 3 studies; hospital costs were significantly less in the eRas group than in the traditional group in 2 studies, 31, 34 but hospital costs did not differ between groups in 1 study. 33 Anderson 2003 
Publication Bias
We used the egger weighted linear regression test 23 to examine the asymmetry of funnel plots for all 9 meta-analysis outcomes and found that the funnel plots for total hospital stay, readmission rates, mortality, and time to first passage of flatus and stool were symmetrical (p = 0.91, 0.54, 0.32, 0.55, and 0.24). the funnel plots were asymmetrical for primary hospital stay, total complications, general complications, and surgical complications (p = 0.04, 0.02, 0.05, and 0.005).
DISCUSSION
the present meta-analysis showed that eRas programs are associated with a significant reduction in primary and total hospital stay, total and general postoperative complications, and time to first passage of flatus and stool in comparison with traditional perioperative care in patients undergoing elective colorectal surgery. there were no significant differences in readmission rates, surgical complications, and mortality between the groups. the quality of evidence was assessed by using the GRaDe approach ( fig. 12 ). 24 the reasons for the downgraded quality of evidence for each outcome are noted in figure 12 . the meta-analysis of some outcomes showed high statistical heterogeneity, which may have resulted in inconsistency. however, we did not downgrade the quality of evidence because of the heterogeneity, which could be explained by the variation between studies in the number of eRas items incorporated, compliance with eRas items, and definition of discharge criteria and complications.
the present meta-analysis was based on 13 randomized controlled trials and followed the recommendations of the PRisma statement. 17 the present study was strengthened by the inclusion of only randomized controlled trials, stringent inclusion criteria, rigorous search strategy, avoidance of a language limitation, and use of the GRaDe approach to assess the quality of evidence for each outcome. 24 there were several limitations to the present metaanalysis. first, the risk of bias in most included studies was serious. Blinding the surgeons and patients was not possible because of the design of eRas programs. however, blinding of assessors was possible, but only 1 trial Readmission rates (CRITICAL OUTCOME) Total complications (CRITICAL OUTCOME)
General complications (CRITICAL OUTCOME)
Surgical complications (CRITICAL OUTCOME)
Mortality (CRITICAL OUTCOME)
The time to rst passage of atus (IMPORTANT OUTCOME; Better indicated by lower values)
The time to rst passage of stool (IMPORTANT OUTCOME; Better indicated by lower values) 
Summary of Findings
The mean the time to rst passage of stool in the intervention groups was 1.12 lower (1.37 to 0.87 lower) 1351 (6 studies) 30 days no serious inconsistency 1 None of the included studies were blinded, except for one study by Ren L et al. 34 performed blinding of outcome assessors. Both groups were cared for on same ward and/or low compliance of ERAS items in most included studies 2 Egger weighted linear regression test showed that the funnel plot was asymmetric. 3 None of the included studies were blinded. Both groups were cared for on same ward and/or low compliance of ERAs items in most included studies. 4 Very small number of events, and 95% con dence interval was too wide. performed adequate blinding of assessors. 34 in addition, patients in the groups were treated on the same ward. failure to report compliance or low compliance of eRas items also may have resulted in increased risk of bias. second, high heterogeneity was identified in the primary and total hospital stay and time to first passage of flatus and stool. however, the heterogeneity could be explained, and the eRas groups consistently showed a benefit in these outcomes. third, the funnel plots were asymmetrical for some outcomes, which indicated the existence of publication bias. however, other factors such as study size and clinical and statistical heterogeneity may also cause an asymmetric funnel in the present meta-analysis. 23 fourth, the confidence in the findings was limited because the quality of the evidence for all outcomes was low to moderate on the GRaDe scale, and none had high quality. this reduces confidence in the findings. fifth, the present results cannot be generalized to elderly patients because only 1 included study assessed eRas programs in elderly patients. 36 finally, the included studies did not adequately evaluate hospital costs and quality of life after surgery, which are important outcomes for patients undergoing elective colorectal surgery.
there have been 7 previously published systematic reviews, including meta-analyses on this topic. [10] [11] [12] [13] [14] [15] [16] these have included 3 reviews of controlled clinical trials and randomized controlled trials 10,12,13 and 4 reviews of randomized controlled trials only.
11,14-16 the present meta-analysis included 13 studies, and 8 of these studies (1522 patients) were published after the most recently published meta-analysis. 16 the present study is the first meta-analysis of patients undergoing elective colorectal surgery to demonstrate that eRas programs are associated with a significant reduction in general postoperative complications and time to first passage of flatus and stool compared with traditional perioperative care. the present results confirmed previous findings that eRas programs are associated with decreased postoperative hospital stay and total postoperative complications, but no significant reduction in readmission rates and mortality. the quality of evidence from the present study was supported by the increased number of included studies.
CONCLUSION
although eRas programs in colorectal surgery were introduced years ago, implementation in daily clinical practice has been slow. [38] [39] [40] [41] the evidence from the present meta-analysis shows that eRas programs are safe and effective, and increased use of eRas programs is justified for perioperative care in patients undergoing elective colorectal surgery. implementation of eRas programs and the maintenance of compliance may require collaboration and communication between dietitians, nurses, surgeons, anesthesiologists, and patients. additional randomized controlled trials of eRas programs with long-term followup are necessary to assess hospital costs and quality of life after surgery. furthermore, future study may assess the benefits of eRas programs in elderly patients and patients having other Gi surgery.
